Patents-Review.com
🔗 Permalink
Assignee profile:

CANTARGIA AB

City:

Lund

Country:

Sweden

Published Applications:

19

Last publication date:

2025-11-06

Patent Grants:

18

Last grant date:

2024-07-23

Top Inventors for applications by CANTARGIA AB

These are the the leading inventors for applications assigned to CANTARGIA AB:

Recent patent applications by CANTARGIA AB

CANTARGIA AB based in Lund, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-11-06
US20250340657A1
Chemistry; metallurgy

Methods of Treating IL1RAP Associated Cancers with Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies

 #2 | 2023-04-06 ✅ Patent 12,043,666 granted on 2024-07-23
US20230108007A1
Chemistry; metallurgy

Anti-IL1RAP antibody

 #3 | 2022-08-25 ✅ Patent 12,209,131 granted on 2025-01-28
US20220267454A1
Chemistry; metallurgy

Anti-IL1RAP antibody compositions

 #4 | 2022-08-04 ✅ Patent 11,479,610 granted on 2022-10-25
US20220242950A1
Chemistry; metallurgy

Anti-IL1RAP antibody

 #5 | 2022-04-07 ✅ Patent 12,398,213 granted on 2025-08-26
US20220106396A1
Chemistry; metallurgy

Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies and Uses Thereof

 #6 | 2021-08-26 ✅ Patent 11,773,174 granted on 2023-10-03
US20210261674A1
Chemistry; metallurgy

Anti-IL1RAP antibodies and their use for treating humans

 #7 | 2020-10-29 ✅ Patent 11,236,172 granted on 2022-02-01
US20200339696A1
Chemistry; metallurgy

Methods of producing an IL-1 RAP antibodies

 #8 | 2019-11-07 ✅ Patent 11,359,025 granted on 2022-06-14
US20190338038A1
Chemistry; metallurgy

Anti-IL1-RAP antibodies

 #9 | 2019-07-04 ✅ Patent 10,752,692 granted on 2020-08-25
US20190202924A1
Chemistry; metallurgy

Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof

 #10 | 2018-12-13 ✅ Patent 10,562,971 granted on 2020-02-18
US20180355049A1
Chemistry; metallurgy

Method of detection of IL1RAP on cells expressing the protein

 #11 | 2018-11-22 ✅ Patent 10,995,144 granted on 2021-05-04
US20180334506A1
Chemistry; metallurgy

Methods of detecting a solid tumor with anti-IL1RAP antibodies

 #12 | 2018-10-11 ✅ Patent 10,878,703 granted on 2020-12-29
US20180293895A1
Physics

Method of treatment of leukemia with anti-IL1RAP antibodies

 #13 | 2018-02-15 ✅ Patent 10,100,119 granted on 2018-10-16
US20180044425A1
Chemistry; metallurgy

Anti-human interleukin-1 receptor accessory protein antibody and its use for treating cancer

 #14 | 2018-01-04 ✅ Patent 10,287,357 granted on 2019-05-14
US20180002430A1
Chemistry; metallurgy

Methods of treating cancer using anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies

 #15 | 2017-07-13 ✅ Patent 10,005,842 granted on 2018-06-26
US20170198048A1
Chemistry; metallurgy

Method of treatment for leukemia using an anti-IL1RAP antibody

 #16 | 2017-03-23 ✅ Patent 10,005,841 granted on 2018-06-26
US20170081414A1
Chemistry; metallurgy

Method of treating a solid tumor with IL1RAP antibodies

 #17 | 2017-02-02 ✅ Patent 9,796,783 granted on 2017-10-24
US20170029516A1
Chemistry; metallurgy

Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof

 #18 | 2014-01-16 ✅ Patent 9,403,906 granted on 2016-08-02
US20140017167A1
Chemistry; metallurgy

Method of treatment of a solid tumor with interleukin-1 accessory protein antibody

 #19 | 2012-09-06 ✅ Patent 9,458,237 granted on 2016-10-04
US20120225059A1
Chemistry; metallurgy

Method for inducing cell death in acute lymphoblastic leukemic system cells

Also check out Cantargia AB's (Lund, Sweden) applicant profile with 17 patent applications submitted.

AssigneeID:

51925 ⎘